Genetic networks

Genetic Networks' Founder and CEO Gennaro D'Urso joins I.D.E.A.S. 2022 to discuss the research his company has done during the Covid-19 pandemic and how that has inspired his plans to decentralize the pharmaceutical industry through a collaboration with a decentralized autonomous organization (DAO).

13 déc. 2022

Genetic Networks Founder and Chairman Gennaro D’Urso shares an example of a "frustrating" experience of bringing a drug to market by having to ask for funding from the government. "Usually it's money that prevents you from moving fast." He joined "First Mover" live at CoinDesk's I.D.E.A.S. to explain how PharmaDAO could solve this problem.

18 oct. 2022

Genetic Networks founder and chairman Gennaro D'Urso joins "First Mover" to discuss how PharmaDAO could change the future of the pharmaceutical industry following the fallout of a global pandemic.

18 oct. 2022

Genetic Networks founder and chairman Gennaro D'Urso joins "First Mover" host Christine Lee and DeFi Education Fund’s Policy Director Miller Whitehouse-Levine to discuss the limitations of the pharmaceutical industry and ways in which DAOs can benefit drug discovery.

18 oct. 2022

LinksDAO founder Mike Dudas, Genetic Networks founder & CEO Gennaro D'Urso and Tribute Labs CEO Aaron Wright join Consensus 2022 to discuss shared wallets and an outlook on the future of DAO. Moderator: Tracy Wang, senior reporter, CoinDesk

4 août 2022

Genetic Networks Founder & CEO Gennaro D'Urso joins Khayyam Wakil (Champagne DAO) at Consensus 2022 to discuss the potential of using DAOs to develop medicine and pharmaceutical products.

2 août 2022